title: Linear IgA bullous dermatosis following human papillomavirus vaccination.
authors.forename: Shigeki
authors.initials: S
authors.lastname: Ikeya
authors.forename: Shoko
authors.initials: S
authors.lastname: Urano
authors.forename: Yoshiki
authors.initials: Y
authors.lastname: Tokura
mesh_terms: D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use; D003875:Drug Eruptions / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D062027:Linear IgA Bullous Dermatosis / Q000139:chemically induced* / Q000188:drug therapy; D053918:Papillomavirus Vaccines / Q000009:adverse effects*; D011239:Prednisolone / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D003879:Dermatologic Agents; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines; D016572:Cyclosporine; D011239:Prednisolone